Henry J. Lin, M.D.

Professor of Pediatrics
Chief, Division of Medical Genetics

Certifications:
American Board of Internal Medicine
American Board of Medical Genetics (Clinical Genetics)
American Board of Medical Genetics (Clinical Molecular Genetics)

Education and Training:
A.B., University of California, Berkeley
M.D., Harvard Medical School, Boston, Massachusetts
Internship/Residency, Internal Medicine, Harbor-UCLA Medical Center
Fellowship, NIH Interinstitute Medical Genetics Training Program

Research interests:
Genes and cancer

Selected publications:

Park JM, Kanaoka Y, Eguchi N, Aritake K, Grujic S, Materi AM, Buslon VS, Tippin BL, Kwong AM, Salido E, French SW, Urade Y, Lin HJ. Hematopoietic prostaglandin D synthase suppresses intestinal adenomas in ApcMin/+ mice. Cancer Res 67:881-889 (2007).

Lin HJ, Lakkides KM, Keku TO, Reddy ST, Louie AD, Kau IH, Zhou H, Gim JSY, Ma HL, Matthies CF, Dai A, Huang H-F, Materi AM, Lin JH, Frankl HD, Lee ER, Hardy SI, Herschman HR, Henderson BE, Kolonel LN, Le Marchand L, Garavito RM, Sandler RS, Haile RW, Smith WL. Prostaglandin H synthase 2 variant (Val511Ala) in African Americans may reduce the risk for colorectal neoplasia. Cancer Epidemiol Biomark Prev 11:1305-1315 (2002).

Lin HJ, Probst-Hensch NM, Louie AD, Kau IH, Witte JS, Ingles SA, Frankl HD, Lee ER, Haile RW. Glutathione transferase null genotype, broccoli, and lower prevalence of colorectal adenomas. Cancer Epidemiol Biomark Prev 7:647-652 (1998).